ANI Expects Growth From Launches And Novitium Integration

As Company Expects Cortrophin Gel To Have Commercial Longevity

 
• By Akriti Seth
  
Launch
ANI Pharma expects the company to grow on the back of lead assets like Cortrophin Gel • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business